In response to growing concerns regarding the quality of imported medications, authorities in the Maldives have bolstered inspections at ports that handle medicine imports. This move comes after India's Central Drugs Standard Control Organization (CDSCO) flagged quality issues with 48 medications produced in the country.
The Maldives Food and Drug Authority (MFDA) announced today that it has conducted a thorough market evaluation to determine whether these affected drugs are present in the Maldives and if they are included in the approved drug list. Following this evaluation, the MFDA confirmed that none of the problematic medication batches identified by the CDSCO have been imported into the Maldives through official channels.
Despite the reassurances, the MFDA has urged the public to exercise caution. With many Maldivians traveling to India for medical treatment, it is common for individuals to bring back medications for personal use. This practice raises the risk of unapproved or substandard drugs entering the local market.
"As a precautionary measure, we will continue to strengthen inspections at ports importing drugs into Maldives and take all necessary measures to prevent the entry of such drugs," the MFDA stated in its alert.
Members of the public are encouraged to reach out to the MFDA at 7200321 for any inquiries regarding medications or to report any suspicious products.
